Evans Eric, Zengul Ayse, Hall Allyson, Qu Haiyan, Willig Amanda, Cherrington Andrea, Thirumalai Mohanraj
Department of Health Services Administration, University of Alabama at Birmingham, Birmingham, AL, United States.
Department of Nutrition Sciences, University of Alabama at Birmingham, Birmingham, AL, United States.
JMIR Res Protoc. 2021 Sep 10;10(9):e31689. doi: 10.2196/31689.
Individuals with disabilities and type 2 diabetes require self-management programs that are accessible, sustainable, inclusive, and adaptable. Health coaching has been shown to be an effective approach for improving behavioral changes in self-management. Health coaching combined with telehealth technology has the potential to improve the overall quality of and access to health services.
This protocol outlines the study design for implementing the Artificial Intelligence for Diabetes Management (AI4DM) intervention. The protocol will assess the feasibility, acceptability, and preliminary efficacy of the AI4DM telehealth platform for people with disabilities.
The AI4DM study is a 2-arm randomized controlled trial for evaluating the delivery of a 12-month intervention, which will involve telecoaching, diabetes educational content, and technology access, to 90 individuals with diabetes and physical disabilities. The hypothesis is that this pilot project is feasible and acceptable for adults with permanently impaired mobility and type 2 diabetes. We also hypothesize that adults in the AI4DM intervention groups will have significantly better glycemic control (glycated hemoglobin) and psychosocial and psychological measures than the attention control group at the 3-, 6-, and 12-month follow-ups.
The AI4DM study was approved by the university's institutional review board, and recruitment and enrollment will begin in October 2021.
The AI4DM study will improve our understanding of the feasibility and efficacy of a web-based diabetes self-management program for people with disabilities. The AI4DM intervention has the potential to become a scalable and novel method for successfully managing type 2 diabetes in people with disabilities.
ClinicalTrials.gov NCT04927377; https://clinicaltrials.gov/ct2/show/NCT04927377.
INTERNATIONAL REGISTERED REPORT IDENTIFIER (IRRID): PRR1-10.2196/31689.
残疾人和2型糖尿病患者需要可及、可持续、包容且适应性强的自我管理项目。健康指导已被证明是改善自我管理中行为改变的有效方法。将健康指导与远程医疗技术相结合,有可能提高医疗服务的整体质量和可及性。
本方案概述了实施糖尿病管理人工智能(AI4DM)干预的研究设计。该方案将评估AI4DM远程医疗平台对残疾人的可行性、可接受性和初步疗效。
AI4DM研究是一项双臂随机对照试验,用于评估对90名患有糖尿病和身体残疾的个体进行为期12个月的干预措施的效果,该干预措施将包括远程指导、糖尿病教育内容和技术接入。假设是该试点项目对行动永久受限的2型糖尿病成年人是可行且可接受的。我们还假设,在3个月、6个月和12个月的随访中,AI4DM干预组的成年人在血糖控制(糖化血红蛋白)以及社会心理和心理指标方面将显著优于注意力控制组。
AI4DM研究已获得大学机构审查委员会的批准,招募工作将于2021年10月开始。
AI4DM研究将增进我们对基于网络的糖尿病自我管理项目对残疾人的可行性和疗效的理解。AI4DM干预有可能成为成功管理残疾人2型糖尿病的一种可扩展的新方法。
ClinicalTrials.gov NCT04927377;https://clinicaltrials.gov/ct2/show/NCT04927377。
国际注册报告识别码(IRRID):PRR1-10.2196/31689。